| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 3,120,005 | 2,478,028 | 2,654,319 | 4,150,936 | | Cost of Revenue | 3,000,851 | 2,539,904 | 2,778,324 | 3,670,629 | | | Gross Profit | 119,154 | (61,876) | (124,005) | 480,307 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 105,913 | 106,925 | 125,376 | 145,343 | | Non Recurring |
-
|
-
|
-
| 105,183 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,241 | (168,801) | (249,381) | 229,781 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 3,520 | 7,317 | 11,112 | | Earnings Before Interest And Taxes | (96,643) | (165,281) | (242,064) | 182,892 | | Interest Expense | (75,159) | 35,477 | 39,682 | 33,486 | | Income Before Tax | (21,484) | (200,758) | (281,746) | 149,406 | | Income Tax Expense | (16,173) | (72,989) | (91,221) | 43,514 | | Minority Interest |
-
|
-
|
-
| (58,001) | | | | Net Income From Continuing Ops | (34,226) | (127,769) | (190,525) | 105,892 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (34,226) | (127,769) | (190,525) | 105,892 | | Preferred Stock And Other Adjustments | 4,688 | (5,568) | 880 |
-
| | | Net Income Applicable To Common Shares | ($29,538) | ($133,337) | ($189,645) | $105,892 |
|
1.23% Nasdaq 
Income Statement
